Inactivation of mprF affects vancomycin susceptibility in Staphylococcus aureus

Biochimica et Biophysica Acta - General Subjects

Volumn 1621, Issue 2, 2003, Pages 117-121

  Ruzin, Alexey ^a,c   Severin, Anatoly ^a   Moghazeh, Soraya L ^a   Etienne, Jerome ^b   Bradford, Patricia A ^a   Projan, Steven J ^a   Shlaes, David M ^a,d  

^a WYETH RESEARCH   (United States)

^b INSERM   (France)

^c Idenix Pharmaceuticals ^*  (United States)

^d Idenix Pharmaceuticals Inc   (United States)

Author keywords

Inactivation; Staphylococcus aureus; Vancomycin

Indexed keywords

VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATION; BACTERIUM MUTANT; GENE INACTIVATION; GENE INSERTION; GENE MAPPING; GENETIC COMPLEMENTATION; GENETIC LINKAGE; MEMBRANE BINDING; MINIMUM INHIBITORY CONCENTRATION; MUTAGENESIS; NONHUMAN; NORTHERN BLOTTING; PHENOTYPE; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS;

INSERTION SEQUENCES; STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS;

EID: 0037414507     PISSN: 03044165     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-4165(03)00028-X     Document Type: Article

References (22)

1. MMWR, Morb. Mortal. Wkly. Rep. 51:2002;565-567.
2. Sieradzki K., Tomasz A. J. Bacteriol. 179:1997;2557-2566.
3. Cui L., Murakami H., Kuwahara-Arai K., Hanaki H., Hiramatsu K. Antimicrob. Agents Chemother. 44:2000;2276-2285.
4. Peschel A., Vuong C., Otto M., Gotz F. Antimicrob. Agents Chemother. 44:2000;2845-2847.
5. Shlaes D.M., Shlaes J.H., Vincent S., Etter L., Fey P.D., Goering R.V. Antimicrob. Agents Chemother. 37:1993;2432-2437.
6. Sieradzki K., Pinho M.G., Tomasz A. J. Biol. Chem. 274:1999;18942-18946.
7. Kuroda M., Kuwahara-Arai K., Hiramatsu K. Biochem. Biophys. Res. Commun. 269:2000;485-490.
8. Brandenberger M., Tschierske M., Giachino P., Wada A., Berger-Bachi B. Biochim. Biophys. Acta. 1523:2000;135-139.
9. Bischoff M., Berger-Bachi B. Antimicrob. Agents Chemother. 45:2001;1714-1720.
10. Kaatz G.W., Seo S.M., Dorman N.J., Lerner S.A. J. Infect. Dis. 162:1990;103-108.
11. Peschel A., Jack R.W., Otto M., Collins L.V., Staubitz P., Nicholson G., Kalbacher H., Nieuwenhuizen W.F., Jung G., Tarkowski A., van Kessel K.P., van Strijp J.A. J. Exp. Med. 193:2001;1067-1076.
12. Youngman P. Hardy K.G. Plasmids, A Practical Approach. 1987;79-103 IRL Press Oxford, Washington, DC.
13. Novick R.P. Miller J. Methods in Enzymology. vol. 204:1991;587-636 Academic Press, Orlando.
14. Cheung A.L., Eberhardt K., Heinrichs J.H. Infect. Immun. 65:1997;2243-2249.
15. Mahmood R., Khan S.A. J. Biol. Chem. 265:1990;4652-4656.
16. National Committee for Clinical Laboratory Standards, National Committee for Clinical Laboratory Standards, Wayne, PA, 2000.
17. Current Protocols in Molecular Biology, Greene Publishing Associates and Wiley-Interscience, New York, 1987.
18. Spratt B.G. Eur. J. Biochem. 72:1977;341-352.
19. Yang Y., Bhachech N., Bush K. J. Antimicrob. Chemother. 35:1995;75-84.
20. Inman E.L. J. Chromatogr. 410:1987;363-372.
21. van Heijenoort Y., Gomez M., Derrien M., Ayala J., van Heijenoort J. J. Bacteriol. 174:1992;3549-3557.
22. Bobin-Dubreux S., Reverdy M.E., Nervi C., Rougier M., Bolmstrom A., Vandenesch F., Etienne J. Antimicrob. Agents Chemother. 45:2001;349-352.